XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.1
EQUITY BASED COMPENSATION
3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Equity Based Compensation . EQUITY BASED COMPENSATION

 

In February 2021, Greenidge adopted an equity incentive plan and reserved 3,831,112 shares of class A common stock for issuance under the plan (the “2021 Equity Plan”).

 

Restricted Common Stock Unit Awards

During the three months ended March 31, 2022, the Company awarded 5,335 restricted common stock units (“RSUs”) under the 2021 Equity Plan to employees, which are generally eligible to vest over a three-year period.

 

The Company’s unvested RSU awards activity for the three months ended March 31, 2022 is summarized below:

 

 

 

 

 

Weighted Average

 

 

 

 

 

Grant Date

 

 

RSUs

 

 

Fair Value

 

Unvested at December 31, 2021

 

516,987

 

 

$

6.80

 

Granted

 

5,335

 

 

 

15.32

 

Vested

 

(90,704

)

 

 

6.25

 

Unvested at March 31, 2022

 

431,618

 

 

$

7.01

 

 

The value of RSU grants is measured based on their fair market value on the date of grant and amortized over their requisite service periods. During the three months ended March 31, 2022, the fair market value of the awards granted totaled $0.1 million, and as of March 31, 2022, there was approximately $2.4 million of total unrecognized compensation cost related to unvested restricted stock rights, which is expected to be recognized over a remaining weighted-average vesting period of approximately 2.0 years.

 

Common Stock Options

 

The Company’s common stock options activity for the three months ended March 31, 2022 is summarized below:

 

 

 

 

 

 

 

 

Weighted Average

 

 

 

 

 

 

 

 

Weighted Average

 

 

Remaining

 

 

Aggregate

 

 

 

 

 

Exercise Price

 

 

Contractual Life

 

 

Intrinsic

 

 

Options

 

 

Per Share

 

 

(in years)

 

 

Value

 

Outstanding at December 31, 2021

 

583,080

 

 

$

6.01

 

 

9.2

 

 

$

5,854

 

Granted

 

-

 

 

 

-

 

 

 

 

 

 

 

Exercised

 

(334

)

 

 

6.25

 

 

 

 

 

 

 

Forfeited

 

(2,888

)

 

 

6.25

 

 

 

 

 

 

 

Outstanding at March 31, 2022

 

579,858

 

 

$

6.01

 

 

 

8.9

 

 

$

1,430

 

Exercisable as of March 31, 2022

 

439,225

 

 

$

5.86

 

 

 

8.9

 

 

$

1,150

 

 

The value of common stock option grants is measured based on their fair market value on the date of grant and amortized over their requisite service periods. As of March 31, 2022, there was approximately $0.3 million of total unrecognized compensation cost related to unvested common stock options, which is expected to be recognized over a remaining weighted-average vesting period of approximately 1.4 years.

 

Stock-based Compensation

The Company recognized stock-based compensation expense of $0.4 million and $0.7 million during the three months ended March 31, 2022 and 2021, respectively. Stock-based compensation expense is included in selling, general and administrative expenses in the accompanying unaudited condensed consolidated statements of operations and comprehensive (loss) income.